[company_age]3.0[/company_age][employees]2-10 employees[/employees][funding]Seed[/funding][description]Nuage Therapeutics is a biotechnology company that develops drugs targeting intrinsically disordered proteins (IDPs). IDPs are a class of proteins that lack a fixed three-dimensional structure, making them difficult to target with traditional drug discovery methods. Nuage Therapeutics has developed a platform that uses chemical biology and biomolecular condensation to identify and develop small molecule modulators of IDPs. The company's lead program is focused on developing a drug for the treatment of cancer. Nuage Therapeutics is headquartered in Barcelona, Spain.[/description][ps]Nuage Therapeutics develops small molecule modulators of intrinsically disordered proteins for the treatment of challenging indications.[/ps]